Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Kimhy

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Journal of Personality Disorders|March 2, 2021
Alexithymia, Affective Lability, Impulsivity, and Childhood Adversity in Borderline Personality DisorderEmily R Edwards, Nina L J Rose, Molly Gromatsky, et al.
Schizophrenia Bulletin|March 26, 2015
The Impact of Aerobic Exercise on Brain-Derived Neurotrophic Factor and Neurocognition in Individuals With Schizophrenia: A Single-Blind, Randomized Clinical TrialDavid Kimhy, Julia Vakhrusheva, Matthew N Bartels, et al.
Journal of Psychopathology and Clinical Science|June 25, 2026
Understanding and challenging epistemically suspect beliefs: A call for expanding interdisciplinary researchMichael V Bronstein, Philip Corlett, David Kimhy, et al.
Schizophrenia Research|October 9, 2021
An integrative study of the microbiome gut-brain-axis and hippocampal inflammation in psychosis: Persistent effects from mode of birthPeter Joe, Jose C Clemente, Enrica Piras, et al.
Schizophrenia Research|December 16, 2011
Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophreniaDaniel C Javitt, Robert W Buchanan, Richard S E Keefe, et al.
Biological Psychiatry|December 15, 2010
A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophreniaRobert W Buchanan, Richard S E Keefe, Jeffrey A Lieberman, et al.
Schizophrenia Research. Cognition|December 14, 2019
The characteristics of cognitive neuroscience tests in a schizophrenia cognition clinical trial: Psychometric properties and correlations with standard measuresMichael S Kraus, James M Gold, Deanna M Barch, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Journal of Personality Disorders|March 2, 2021
Alexithymia, Affective Lability, Impulsivity, and Childhood Adversity in Borderline Personality DisorderEmily R Edwards, Nina L J Rose, Molly Gromatsky, et al.
Schizophrenia Bulletin|March 26, 2015
The Impact of Aerobic Exercise on Brain-Derived Neurotrophic Factor and Neurocognition in Individuals With Schizophrenia: A Single-Blind, Randomized Clinical TrialDavid Kimhy, Julia Vakhrusheva, Matthew N Bartels, et al.
Journal of Psychopathology and Clinical Science|June 25, 2026
Understanding and challenging epistemically suspect beliefs: A call for expanding interdisciplinary researchMichael V Bronstein, Philip Corlett, David Kimhy, et al.
Schizophrenia Research|October 9, 2021
An integrative study of the microbiome gut-brain-axis and hippocampal inflammation in psychosis: Persistent effects from mode of birthPeter Joe, Jose C Clemente, Enrica Piras, et al.
Schizophrenia Research|December 16, 2011
Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophreniaDaniel C Javitt, Robert W Buchanan, Richard S E Keefe, et al.
Biological Psychiatry|December 15, 2010
A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophreniaRobert W Buchanan, Richard S E Keefe, Jeffrey A Lieberman, et al.
Schizophrenia Research. Cognition|December 14, 2019
The characteristics of cognitive neuroscience tests in a schizophrenia cognition clinical trial: Psychometric properties and correlations with standard measuresMichael S Kraus, James M Gold, Deanna M Barch, et al.
Pageof 7